QR Code

Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors

Brain metastases are a devastating sequela of common primary cancers (e.g., lung, breast, and skin) and have limited effective therapeutic options. Previously, systemic chemotherapy failed to demonstrate significant benefit in patients with brain metastases, but in recent decades, targeted therapies...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Jennifer K. Matsui, Haley K. Perlow, Rohit K. Raj, Ansel P. Nalin, Eric J. Lehrer, Rupesh Kotecha, Daniel M. Trifiletti, Shearwood McClelland, Kari Kendra, Nicole Williams, Dwight H. Owen, Carolyn J. Presley, Evan M. Thomas, Sasha J. Beyer, Dukagjin M. Blakaj, Manmeet S. Ahluwalia, Raju R. Raval, Joshua D. Palmer
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2022-09-01
Rangatū:Biomedicines
Ngā marau:
brain metastases
radiotherapy
radiation therapy
systemic therapy
immune checkpoint inhibitors
immunoradiotherapy
Urunga tuihono:https://www.mdpi.com/2227-9059/10/9/2211
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite